Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is This Dividend Growth Stock a Buy?

TheMotleyFool

0 0

Concerns about inflation -- and now, a possible recession -- have led the S&P 500 index to drop 17% so far this year. But some stocks have fared much better than the broader market.

The pharma stock Eli Lilly (NYSE: LLY) has surged 13% higher year to date. But has the stock's rally made it too expensive? Let's dive into Eli Lilly's fundamentals and valuation to find out.

Eli Lilly reported $7.8 billion in revenue for the first quarter ended March 31, up 14.8% from the year-ago period. How did the large-cap company deliver double-digit revenue growth to its shareholders in the first quarter?

Source Fool.com

Like: 0

LLY

Share